Typhim VI 25 MCG/0.5 ML syrng 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM9G2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $53,648
Award facts
- Contract value 100% obligated
- $53,647.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $53,647.50 with a completion date of January 9, 2026, was awarded on January 8, 2026, to AmerisourceBergen Drug Corp for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. The Defense Logistics Agency (DLA) issued this competitive, firm fixed-price contract without set-aside designation to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with performance conducted at its corporate office location in the same city. The contract falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026, which provides a comprehensive vehicle for supplying pharmaceutical products and medical supplies to military healthcare programs globally.
AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor providing critical medical commodities to federal agencies including the Department of Defense and Department of Veterans Affairs. The IDC vehicle under which this delivery order was issued encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. Through this structured contracting approach, the Defense Logistics Agency ensures reliable access to essential pharmaceutical products required by military treatment facilities and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FM9G2?
SPE2DR26FM9G2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FM9G2 worth?
The government has obligated $53,648 on SPE2DR26FM9G2.
Is contract SPE2DR26FM9G2 an order under another contract?
Yes. SPE2DR26FM9G2 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM9G2 competed?
The extent of competition for SPE2DR26FM9G2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award